Argent Biopharma’s (RGT) flagship CannEpil cannabis drug is set to pivot into the veterinary market, just weeks after it signed away the commercial rights in exchange for debt relief.
Ananda Pharma [stock_market_widget type=”chart” template=”line” assets=”ANANF” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Just days after welcoming the former Chief Operating Officer of GW and Jazz Pharmaceuticals to its ranks Ananda has announced its entrance onto the US OTCQB Exchange, opening up its stock to US investors.
Argent BioPharma [stock_market_widget type=”chart” template=”line” assets=”RGT.AX” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Argent BioPharma has managed to overcome the wider chaos on the stock markets this week, seeing its stock jump over 40% in the wake of two major announcements.
UK-listed medical cannabis producer Celadon Pharmaceuticals is struggling to emerge from its precarious financial position after months of turmoil.
Akanda [stock_market_widget type=”chart” template=”line” assets=”AKAN” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Akanda Corp has become the latest listed cannabis company to announce its (partial) exit from the industry as it pivots from medical cannabis cultivation in Europe to telecommunications in South America.
Aurora Cannabis [stock_market_widget type=”chart” template=”line” assets=”ACB” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Canadian cannabis giant Aurora Cannabis has seen its stock jump nearly 50% this week after publishing a record-breaking financial performance in its third quarter.
Argent BioPharma [stock_market_widget type=”chart” template=”line” assets=”RGT.AX” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Argent Biopharma (previously MGC Pharmaceuticals) has completed a US$4.5 million capital raise to support its drug development efforts, just weeks after delisting from the London Stock Exchange.
Argent Biopharma [stock_market_widget type=”chart” template=”line” assets=”RGT.L” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Argent Biopharma (previously MGC Pharmaceuticals), the first company in history to launch an IPO on the London Stock Exchange, has announced its intention to de-list from the exchange.
Akanda Corp [stock_market_widget type=”chart” template=”line” assets=”AKAN” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] NASDAQ-listed international medical cannabis operator Akanda Corp has seen its stock drop by double digits this week amid the release of its half-year results.
